Catalyst Wire Dossier Catalyst Wire Dossier

Akkermansia muciniphila

Akkermansia muciniphila · Wecare Probiotics Co., Ltd.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Akkermansia muciniphila, covering 2025-05-28 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Effects of Akkermansia Muciniphila and Berberine Supplementation on Insulin Sensitivity in Night-shift Workers [NA]

See pricing